Deal Announcement
Evernile Capital advises Usmanpura Imaging Centre (UIC) on its growth capital raise from OFAAFO Advisors
Announced Date: JULY 2026
Evernile Capital acted as exclusive financial advisor to Usmanpura Imaging Centre (UIC) and its promoters, Dr. Amit Gupta and Dr. Aradhana Gupta, on growth capital raise from OFAAFO Advisors.
UIC has raised growth capital to accelerate the expansion of its diagnostics platform across Gujarat and the wider western India market. The Company intends to direct the proceeds toward network expansion into new geographies, upgrading imaging infrastructure and modality capability across its centres, and deepening its integrated radiology-and-pathology offering.

OFAAFO Advisors is a family office that invests across healthcare, consumer, financial services and technology, partnering with founders over a long-term horizon. The investment in UIC is made from a strategic lens, reflecting OFAAFO's focus on the Indian healthcare sector and its conviction in the formalisation of trusted regional diagnostics brands into scaled, professionally-run platforms.
This partnership marks an important milestone for UIC as we scale our diagnostics platform across Gujarat and beyond. The capital will directly support our expansion into new markets, continued investment in advanced imaging technology, and our commitment to accessible, high-quality diagnostics. We are pleased to partner with OFAAFO Advisors, whose long-term and healthcare-focused approach aligns closely with our vision.
Dr. Amit Gupta, Promoter, Usmanpura Imaging Centre
UIC has built a well respected regional platform anchored in clinical excellence and standardized operational processes. As demand for trusted, high-quality diagnostics grows across India, UIC is exceptionally well-positioned to scale its footprint. We are thrilled to partner with Dr. Amit Gupta and Dr. Aradhana Gupta to support their next phase of expansion across India
Siddhi Kaul, CEO, OFAAFA Advisors
UIC is a strong example of how a doctor-led regional diagnostics brand, built on decades of clinical trust, can scale into a professionally-run platform. We are proud to have advised the promoters through this raise and to have partnered them with an investor whose healthcare focus and long-term orientation fit the business so well. We wish the UIC team continued success in this next chapter.